Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Maze Therapeutics, Inc. | StockGist | StockGist

Companies
MAZE
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings MAZESCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Maze Therapeutics, Inc.

Filed Feb 6, 2026

Accepted Feb 6, 2026, 12:00 AM ET

CIK 0001842295

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

1,388,583

Reporting Person

Maze Therapeutics, Inc.

Person Type

PN

CUSIP: 578784100

Key Facts

Shares Owned

1,388,583

Recent Filings

Maze Therapeutics, Inc.1 weeks ago

Maze Therapeutics, Inc.1 weeks ago

Maze Therapeutics, Inc.1 months ago

Maze Therapeutics, Inc.1 months ago

Maze Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice